New heart device aims to prevent future strokes by closing a common hole

NCT ID NCT07172464

Recruiting now Disease control Sponsor: Recross Cardio, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 2 times

Summary

This study tests a new device (P3 Occluder) to close a small hole in the heart called a PFO in people who have had a stroke possibly linked to that hole. About 15 adults aged 18-65 will get the device and be followed for up to 5 years to see if it safely and effectively closes the hole and prevents another stroke.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRYPTOGENIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Ischemic Stroke patent foramen ovale stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CRYPTOGENIC STROKE PATENT FORAMEN OVALE PFO PFO - PATENT FORAMEN OVALE PFO-ASSOCIATED STROKE

Contacts and locations

Locations

Columbia University Medical Center/ NewYork Presbyterian Hospital
RECRUITING

New York, New York, 10032, United States
Prisma Health - Upstate
RECRUITING

Greenville, South Carolina, 29605, United States
The Cardiac and Vascular Institute
RECRUITING

Gainsville, Florida, 32669, United States
Tufts Medical Center
RECRUITING

Boston, Massachusetts, 02111, United States
UCLA
RECRUITING

Los Angeles, California, 90095, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.